Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies

Philipp Königshofer, Benedikt Silvester Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, Oleksandr Petrenko, Katharina Wöran, Merima Herac, Judith Stift, Katharina Lampichler, Gerald Timelthaler, David Bauer, Lukas Hartl, Bernhard Robl, Maria Sibila, Bruno K. Podesser, Georg Oberhuber, Philipp Schwabl, Mattias Mandorfer, Michael Trauner, Thomas Reiberger – 29 October 2021

Mucosal‐associated invariant T‐cell tumor infiltration predicts long‐term survival in cholangiocarcinoma

Christine L. Zimmer, Iva Filipovic, Martin Cornillet, Colm J. O’Rourke, Lena Berglin, Hannes Jansson, Dan Sun, Otto Strauss, Laura Hertwig, Helene Johansson, Erik Seth, Ernesto Sparrelid, Joana Dias, Hans Glaumann, Espen Melum, Ewa C. Ellis, Johan K. Sandberg, Jesper B. Andersen, Annika Bergquist, Niklas K. Björkström – 29 October 2021

Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer

Vincenzo Ronca, Matteo Barabino, Roberto Santambrogio, Enrico Opocher, James Hodson, Emanuela Bertolini, Simone Birocchi, Gaetano Piccolo, PierMaria Battezzati, Marco Cattaneo, Gian Marco Podda – 29 October 2021 – In patients with cirrhosis with severe thrombocytopenia (platelet count [PC] <50 × 109/L) and undergoing invasive procedures, it is common clinical practice to increase the PC with platelet transfusions or thrombopoietin receptor agonists to reduce the risk of major periprocedural bleeding.

Validation of Dynamic Aspartate‐to–Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality

In‐Ae Song, Eun Sun Jang, Tak Kyu Oh – 28 October 2021 – The dynamic aspartate‐to–alanine aminotransferase ratio (dAAR) was developed recently to predict the risk of incident chronic liver disease among the Nordic adult population; however, the dAAR has not been externally validated in other ethnic cohorts. Therefore, we aimed to examine the predictive ability of dAAR for liver disease mortality in the South Korean adult population.

Subscribe to